Ms Siobhán McArdle:

The implementation falls to the operational part of the HSE but our clinical colleagues are best placed to advise on that. At the moment, the priority is, as I said, the age cohorts that are more vulnerable to the effects of flu and respiratory disease. Also included are people with chronic disease and people with respiratory illnesses such as chronic obstructive pulmonary disease, COPD. We are very much encouraging people who are living with chronic disease, as well as older people and children who are living with chronic disease to engage. We will be guided by our public health colleagues on the breadth of the population that receives the vaccine. Everybody is invited but particular attention is being given to priority populations. We will be working with our GP colleagues, as well as our community pharmacy within the HSE and our support organisations, in terms of occupational health and supporting our staff to deliver and manage flu in that environment.